InfuSystem Holdings (INFU) Income from Continuing Operations (2010 - 2026)
InfuSystem Holdings (INFU) posted Income from Continuing Operations of 1017000.0 for Q1 2026, down 50.68% on a QoQ basis from 2062000.0 in Q4 2025, and up 562.27% year-over-year from 153562.11 in Q1 2025.
InfuSystem Holdings (INFU) Income from Continuing Operations (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 1017000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 562.27% year-over-year to 1017000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7938000.0 (up 147.29% YoY) and the FY2025 annual result came in at 6627000.0, up 182.6% from the prior year.
- Income from Continuing Operations was 1017000.0 for Q1 2026 at InfuSystem Holdings, down from 2062000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2600000.0 in Q2 2025 and bottomed at 1098000.0 in Q1 2024.
- A 5-year average of 652235.29 and a median of 443000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Peak annual rise in Income from Continuing Operations reached 884.38% in 2024, while the deepest fall reached 266.0% in 2024.
- InfuSystem Holdings' Income from Continuing Operations stood at 138000.0 in 2022, then sank by 30.43% to 96000.0 in 2023, then soared by 884.38% to 945000.0 in 2024, then jumped by 118.2% to 2062000.0 in 2025, then tumbled by 50.68% to 1017000.0 in 2026.
- Business Quant data shows INFU's Income from Continuing Operations at 1017000.0 in Q1 2026, 2062000.0 in Q4 2025, and 2259000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 2.06 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -220,000.00 |
| Dec 31, 2024 | 945,000.00 |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 720,000.00 |
| Jun 30, 2023 | 435,000.00 |
| Mar 31, 2023 | -300,000.00 |
| Dec 31, 2022 | 138,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | -164,000.00 |
| Mar 31, 2022 | -330,000.00 |
| Dec 31, 2021 | 387,000.00 |
| Sep 30, 2021 | -448,000.00 |
| Jun 30, 2021 | 842,000.00 |